Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 3, 2011, Pages 435-439

  Teixeira, Ana L ^a,b   Araújo, António ^a,b   Coelho, Ana ^a,c   Ribeiro, Ricardo ^a,b   Gomes, Mónica ^a,b   Pereira, Carina ^a,b   Medeiros, Rui ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Cancer susceptibility; Lung cancer; NSCLC; Polymorphisms; TGF ; 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TUMOR MICROENVIRONMENT;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79954437963     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0896-6     Document Type: Article

References (34)

1. Berndt SI, Huang WY, Chatterjee N, Yeager M, Welch R, Chanock SJ, Weissfeld JL, Schoen RE, Hayes RB (2007) Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis 28:1965-1970 (Pubitemid 47500610)
2. Bierie B, Moses H (2006) TGF-b: the molecular Jekyll and Hyde of cancer. Nat Rev 6:506-520
3. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor ß in human disease. N England J Med 324:1350-1358 (Pubitemid 30408720)
4. Cohen V, Khuri FR (2004) Chemoprevention of lung cancer. Curr Opin Pulm Med 10:279-283 (Pubitemid 38803120)
5. Colakogullari M, Ulukaya E, Yilmaztepe A, Aymak F, Basturk B, Ursavas A, Oral HB (2008) The involvement of Il-10, IL-6, INF-γ, TNF-α, and TGF-ß gene polymorphisms among Turkish lung cancer patients. Cell Biochem Funct 26:283-290 (Pubitemid 351613166)
6. Domagala-Kulawik J, Hoser G, Safianowska A, Grubek-Jaworska H, Chazan R (2006) Elevated TGF-ß1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer. Arch Immunol Ther Exp 54:143-147 (Pubitemid 44257351)
7. Elliott R, Blobe G (2005) Role of transforming growth factor beta in human cancer. J Clin Oncol 23:2078-2093 (Pubitemid 46211385)
8. Ewart-Toland A, Chan JM, Yuan J, Balmain A, Ma J (2004) A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiol Biomarkers Prev 13:759-764 (Pubitemid 38737864)
9. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Onco 18:581-592 (Pubitemid 46359643)
10. Glick AB (2004) TGFß1, back to the future. Cancer Biol Ther 3:276-283
11. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8:93-97 (Pubitemid 29039053)
12. Jin Q, Hemminki K, Grzybowska E, Klaes R, Söderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Pamula J, Pekala W, Försti A (2004) Polymorphisms and haplotype structures in genes for transforming growth factor ß1 and its receptors in familial and unselected breast cancers. Int J Cancer 112:94-99 (Pubitemid 39249496)
13. Jin G, Deng Y, Miao R, Hu Z, Zhou Y, Tan Y, Wang J, Hua Z, Ding W, Wang L, Chen W, Shen J, Wang X, Xu Y, Shen H (2008) TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population. J Cancer Res Clin Oncol 134:345-351 (Pubitemid 351170056)
14. Kang HG, Chae MH, Park JM, Kim EJ, Park JH, Kam S, Cha SI, Kim CH, Park RW, Park SH, Kim YL, Kim IS, Jung TH, Park JY (2006) Polymorphisms in TGF-beta1 gene and the risk of lung cancer. Lung Cancer 52:1-7 (Pubitemid 43340192)
15. Kang D, Lee KM, Park SK, Berndt SI, Reding D, Chatterjee N, Welch R, Chanock S, Huang W-Y, Hayes RB (2007) Lack of association of transforming growth factor-B1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial. Cancer Epidemiol Biomarkers Prev 16:1303-1305 (Pubitemid 46984976)
16. Kim WS, Park C, Jung YS, Kim HS, Han J, Park CH, Kim K, Kim J, Shim YM, Park K (1999) Reduced transforming growth factor-ß type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Anticancer Res 19:301-306 (Pubitemid 29168253)
17. Kirkbride KC, Blobe GC (2003) Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy. Expert Opin Biol Ther 3:251-261 (Pubitemid 36458757)
18. Kong F, Jirtle RL, Huang DH, Clough RW, Anscher MS (1999) Plasma transforming growth factor-beta1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer 86:1712-1719 (Pubitemid 29513039)
19. Li Z, Habuchi T, Tsuchiya N, Mitsumori K, Wang L, Ohyama C, Sato K, Kamoto T, Ogawa O, Kato T (2004) Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon 10. Carcinogenesis 25:237-240 (Pubitemid 38239807)
20. Marchand L, Haiman CA, van den Berg D, Wilkens LR, Kolonel LN, Henderson BE (2004) T29C polymorphism in the transforming growth factor B1 gene and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 13:412-415 (Pubitemid 38737467)
21. Moore LD, Isayeva T, Siegal GP, Ponnazhagan S (2008) Silencing of transforming growth factor-ß1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Clin Cancer Res 14:4961-4970
22. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T, Takahashi T (1996) Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56:2718-2720 (Pubitemid 26175725)
23. Park KH, Han SG, Whang YM, Lee HJ, Yoo YD, Lee JW, Shin SW, Kim YH (2006) Single nucleotide polymorphisms of the TGFB1 gene and lung cancer risk in a Korean population. Cancer Genet Cytogenet 169:39-44 (Pubitemid 44093732)
24. Prud'homme DJ (2008) Pathobiology of transforming growth factor ß in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87:1077-1091
25. Rich JN, Borton AJ, Wang XF (2001) Transforming growth factor-ß signaling in cancer. Microsc Res Tech 52:363-373 (Pubitemid 32167824)
26. Saunier EF, Akhurst RJ (2006) TGF beta inhibition for cancer therapy. Curr Cancer Drug Targets 6:565-578 (Pubitemid 44691000)
27. Seifart C, Plagens A, Dempfle A, Clostermann U, Vogelmeier C, von Wichert P, Seifart U (2005) TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers 21:157-165 (Pubitemid 41566735)
28. Siegel PM, Massague J (2003) Cytostatic and apoptotic actions of TGF-ß in homeostasis and cancer. Nat Rev Cancer 3:807-820 (Pubitemid 37376979)
29. Spira A, Ettinger DS (2004) Multidisciplinary management of lung cancer. N Engl J Med 350:379-392 (Pubitemid 38101633)
30. Tang B, de Castro K, Barnes HE, Parks WT, Stewart L, Böttinger EP, Danielpour D, Wakefield LM (1999) Loss of responsiveness of to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Cancer Res 59:4834-4842 (Pubitemid 29472885)
31. Teixeira AL, Ribeiro R, Morais A, Lobo F, Fraga A, Pina F, Calais-da-Silva FM, Calais-da-Silva FE, Medeiros R (2009) Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility. Pharmacogenomics J 9:341-346
32. Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, Masuda A, Takahashi T, Takahashi T (1996) Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res 56:5583-5585 (Pubitemid 26422155)
33. Wei Y-S, Zhu Y-H, Du B, Yang ZH, Liang WB, Lv ML, Kuang XH, Tai SH, Zhao Y, Zhang L (2007) Association of transforming growth factor-ß1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta 380:165-169 (Pubitemid 46498056)
34. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y (2000) Association of a T29C polymorphism of the transforming growth factor-beta 1gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101:2783-2787 (Pubitemid 30396007)